Related case:
FISA 2008 FISA vs Alexander Litvintchev, Evgeny Luzyanin & Ivan Podshivalov
January 14, 2008
FISA 2008 FISA vs Russian Rowing Federation (1)
January 27, 2008
FISA 2008 FISA vs Russian Rowing Federation (2)
April 4, 2008

The International Federation of Rowing Associations (FISA) was informed that medical materials were found in a rubbish bin near the hotel used by the Russian team in Lucerne during the World Cup Regatta from 13-15 July 2007.
This comprised intravenous infusion equipment, along with legal substances such as creatine and fructose. The materials were taken to the Anti-Doping Laboratory in Lausanne and analysed. Hereafter the DNA of a total of 8 blood samples, provided by the Russian Athlete’s, matched with the DNA samples from the blood found on the needles.
Hereafter in August 2007 FISA imposed a 2 year period of ineligibility on three Athletes of the Russian team for intravenous infusion of substances for other than a legitimate acute medical treatment.

In September 2007 the International Federation of Rowing Associations (FISA) reported anti-doping rule violations against three Athletes of the Russian men’s eight and against two Athlete’s, Anastasia Fatina and Anastasia Karabelshchikova from the women’s eight, for intravenous infusion with no legitimate medical treatment.
FISA notified the five Athletes and a provisional suspension was ordered.

The Russian Rowing Federation submitted a document which stated that the team doctor did not use intravenous injections to introduce substances to the Athletes.
However in a second submitted document the former team doctor admitted his involvement with intravenous infusions and he did administer intravenous infusions to the three male Athletes as prescribed medical treatment for dehydration and convulsions.
The former team doctor made no comment about the two female Athletes in this case.
In a third document the president of the Russian Rowing Federation stated, in contradiction with the first document, that intravenous infusions took place as legitimate medical treatment for the three male Athletes administered by the team doctor.

In the case of the two female Athletes, the Russian Rowing Federation produced evidence in November 2007 that blood had been drawn in July 2007 from a total of 44 Russian Athletes, including the Athlete’s Fatina and Karabelshchikova, and that the blood was analysed by a laboratory in Moscow for ten parameters.
After further questions, in January 2008, the Russian Rowing Federation produced different evidence that the blood was not transported to Moscow and analysed in Moscow but was, in fact, analysed in a hotel room in Lucerne on a blood analysis machine which contradicts the previous evidence submitted in November 2007.

On the basis of the medical reports provided by the Russian Federation, the Panel finds that the Russian Rowing Federation has presented two different versions of what took place in the hotel room in Lucerne in July 2007 and that both appear not plausible and in contradiction with the evidence. In addition the Panel finds that there has been no credible evidence to support the assertion that blood was drawn from the two female Athletes in Lucerne.
The Panel concludes that the evidence is overwhelming that similar treatments were carried out on all eight Russian Athletes, i.e. infusions or other blood manipulation and that, in all cases, there was no legitimate medical treatment involved. The Panel notes that the contradiction in the Russian statements does raise questions as to the reliability of the submitted evidence.

Therefore the FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete’s Anastasia Fatina and Anastasia Karabelshchikova, starting on 27 August 2007.

Related case:
FISA 2008 FISA vs Anastasia Fatina & Anastasia Karabelshchikova
February 5, 2008
FISA 2008 FISA vs Russian Rowing Federation (1)
January 27, 2008
FISA 2008 FISA vs Russian Rowing Federation (2)
April 4, 2008

The International Federation of Rowing Associations (FISA) was informed that medical materials were found in a rubbish bin near the hotel used by the Russian team in Lucerne during the World Cup Regatta from 13-15 July 2007.
This comprised intravenous infusion equipment, along with legal substances such as creatine and fructose.
The materials were taken to the Anti-Doping Laboratory in Lausanne and analysed. Hereafter the DNA of three of the blood samples, provided by the Russian Athlete’s, matched with the DNA samples from the blood found on the needles.

In September 2007 the International Federation of Rowing Associations (FISA) reported an anti-doping rule violation against the Athletes Alexander Litvintchev, Evgeny Luzyanin and Ivan Podshivalov for intravenous infusion with no legitimate medical treatment. FISA notified the Athletes and a provisional suspension was ordered.
The president of the Russian Rowing Federation filed statements in their defence and appeared for the FISA Doping Hearing Panel on behalf of the Athletes.

FISA had received a document from the Russian Rowing Federation which stated that the team doctor did not use intravenous injections to introduce substances to the Athletes. However in a second document the former team doctor admitted his involvement with intravenous infusions and he did administer intravenous infusions to these three Athletes as prescribed medical treatment for dehydration and convulsions. In a third document the president of the Russian Rowing Federation stated, in contradiction with the first document, that intravenous infusions took place as legitimate medical treatment administered by the team doctor.

On the basis of the medical reports provided by the Russian Federation and the advice of the medical experts, the Panel concludes that the Athletes used a prohibited method, intravenous infusion, for sports recovery purposes, rather than medical treatment. The intravenous infusion of a fructose substance is not a remedy for the illness diagnosed and therefore not a legitimate medical treatment. The Panel notes that the contradiction in the Russian statements does raise questions as to the reliability of the submitted evidence.
The FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete’s, starting on 27 August 2007.

Related cases:
FISA 2008 FISA vs Russian Rowing Federation (1)
January 27, 2008
FISA 2008 FISA vs Russian Rowing Federation (2)
April 4, 2008

The International Federation of Rowing Associations (FISA) was informed that medical materials were found in a rubbish bin near the hotel used by the Russian team in Lucerne during the World Cup Regatta from 13-15 July 2007. This comprised intravenous infusion equipment, along with legal substances such as creatine and fructose. The materials were taken to the Anti-Doping Laboratory in Lausanne and analysed. Hereafter the DNA of two of the blood samples, provided by the Russian Athletes, matched with the DNA samples from the blood found on the needles.

In August 2007 the International Federation of Rowing Associations (FISA) reported an anti-doping rule violation against the Athletes Vladimir Varfolomeev and Denis Moiseev for intravenous infusion with no legitimate medical treatment.
FISA notified the Athletes and a provisional suspension was ordered. The Athletes filed a statement in their defence and were heard for the FISA Doping Hearing Panel.

The Athletes admitted the used intravenous infusions to inject themselves with creatine phosphate. The Athlete’s argued that both had heart conditions and a doctor at a medical institute in Moscow had prescribed creatine phosphate to their condition. The Athletes stated they did not know that intravenous infusion was forbidden.
In support the Athlete’s produced documents of Russian doctors indicating the medical condition of the Athlete’s and the prescribed treatment.

The Panel concludes that the Athlete’s used a prohibited method, intravenous infusion, for sports recovery purposes, rather than medical treatment, without a medical advice or under medical supervision.
Therefore the FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete’s, starting on 27 August 2007.

Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M01 for a violation of the Anti-Doping Rules. During a semi-marathon on December 12, 2010, the respondent evaded and refused to attend a doping test.

History
The athlete didn't attend the doping control because of headaches and vomiting.

Decision
1. The respondent receives a warning.
2. The results obtained at the semi-marathon of December 12, 2010, will be cancelled. Medals, points and prices are withdrawn.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Related cases:
FISA 2008 FISA vs Russian Rowing Federation (1)
January 27, 2008
FISA 2008 FISA vs Russian Rowing Federation (2)
April 4, 2008

In September 2007 the International Federation of Rowing Associations (FISA) has reported an anti-doping rule violation against the Athlete Olga Samulenkova after her A and B samples tested positive for the prohibited substance testosterone with a T/E ratio above the WADA threshold.
FISA notified the Athlete and ordered a provisional suspension. The Athlete did not appear for the FISA Doping Hearing Panel but filed a statement in her defence.

The Athlete submitted a few general claims that the testing procedure might have been incorrectly conducted but did not mention this on the doping control form. The Panel concludes that there is no challenge to the test result and the Athlete failed to explain the finding of the presence of the prohibited substance in her body.
Therefore the FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 23 July 2006.

Related cases:
FISA 2008 FISA vs Russian Rowing Federation (1)
January 27, 2008
FISA 2008 FISA vs Russian Rowing Federation (2)
April 4, 2008

The International Federation of Rowing Associations (FISA) was informed that medical materials were found in a rubbish bin near the hotel used by the Russian team in Lucerne during the World Cup Regatta from 13-15 July 2007.
This comprised intravenous infusion equipment, along with legal substances such as creatine and fructose.
The materials were taken to the Anti-Doping Laboratory in Lausanne and analysed. Hereafter the DNA of one of the blood samples, provided by the Russian Athlete’s, matched with the DNA sample from the blood found on the needles.

In August 2007 the International Federation of Rowing Associations (FISA) reported an anti-doping rule violation against the Athlete Svetlanan Fedorova for intravenous infusion with no legitimate medical treatment.
FISA notified the Athlete and a provisional suspension was ordered. The Athlete filed a statement in her defence and was heard for the FISA Doping Hearing Panel.

The Athlete admitted she treated and infused herself on the last day of the competition with creatine phosphate due to her health problems. The Athlete stated she did not know that intravenous infusion was forbidden.
The Panel concludes that the Athlete had used a prohibited method, namely, intravenous infusion with no legitimate medical treatment and without a legitimate medical treatment involved.
Therefore the FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete, starting on 28 August 2007.

Facts
The French Federation of Billiards (Fédération Française de Billiard, FFB) charges respondent M60 for a violation of the Anti-Doping Rules. During a national championship for pool players on January 20, 2013, a sample for a doping test was taken. The sample tested positive for a metabolite of cannabis. Cannabis is a prohibited substance according the Word Anti-Doping Agency (WADA) prohibited list. Cannabis is regarded as a specified substance.

Decision
1. The decision taken on April 10, 2013, by the disciplinary committee of the FFB is cancelled.
2. The sanction is a period of ineligibility of one year in which respondent can't take part in competition or manifestation organized by the FFB.
3. The period of ineligibility will be reduced by the period of voluntary suspension.
4. All results obtained at the match on January 20, 2013, will be cancelled. Medals, points and price money will be withdrawn.
5. The decision will start on the date of notification.
6. The decision will be published and sent to the parties involved.

The Ukrainian National Rowing Federation has reported an anti-doping violation against the Athlete Nataliya Ryzhkova after her sample tested positive for the prohibited substance stanozolol.
After the notification the Ukrainian National Rowing Federation ordered a provisional suspension. The Athlete did not appear for the FISA Doping Hearing Panel but filed a statement in her defence.

The Athlete stated she had been treated for a long period of time at the Specialized Sports Clinic with little effect for a problem with knee joint bursitis. She then consulted a general practitioner who recommended a course of treatment using medicines which included a substance on the prohibited list. The Athlete argued that general medical reference books do not divide medications into permitted and prohibited drugs. She also stated she desperately wanted to recover as soon as she could to resume her full training and competitive career.

The Panel concludes that the Athlete’s explanation is insufficient and she acted at fault and negligence due to she did not mention the prohibited medication on the doping control form although she did mention other supplements and medications. The Panel finds that Athletes are responsible for the medications or substances they take into their bodies. It is not a sufficient excuse that a substance was prescribed by a general practitioner and that general medical books do not identify permitted and non-permitted substances or that an athlete wants to recover to return to competition.
Therefore the FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 30 April 2007.

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M59 for a violation of the Anti-Doping Rules. During a match on December 9, 2012, a sample was taken for a doping test. The sample tested positive on stanozolol, trenbolone, 19-norandrosterone, boldenone and testosterone or their metabolites. All of these substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent explains that the positive test is caused by supplements he uses for his bodybuilding to increase muscle mass.

Decision
1. The sanction is a period of ineligibility of 3 years in which respondent can't take part in competition or manifestations organized by French sport organizations.
2. The period of ineligibility will be shortened with the period of voluntary suspension.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

The Bulgarian Rowing Federation has reported an anti-doping rule violation against the Athlete Milka Dimitrova Manchorova after her sample tested positive for the prohibited substance recombinant human erythropoetin (rhEPO).
After notification a provisional suspension was ordered by the Bulgarian Rowing Federation.

Without a hearing the FISA Doping Hearing Panel rules on the basis of the written submissions of the Athlete and the Bulgarian Rowing Federation.
The Bulgarian Rowing Federation submitted, on behalf of the Athlete, that the prior to the doping test the Athlete was hospitalised for five day due to heavy drinking resulting in bleedings. In the hospital rhEPO was administered to the Athlete. The Federation indicated that the Athlete has now been retired from competition.

The FISA Doping Hearing Panel is faced with very little evidence consisting only of the hospital report, the explanation given in writing by the federation and the expert medical opinion acquired by FISA. It is not in a strong position to look deeply into the facts, particularly; the reasons behind the hospitalisation and the injury / illness the athlete was suffering; the treatment the athlete received including the administration of rhEPO and the relevance of that treatment; and, the circumstances in which the athlete did not mention the hospitalisation or the medication administered on the form at the time of undergoing the test.

The Panel concludes that the Athlete acted negligently because she failed to research which medication was administered in the hospital and without mentioning the hospitalisation and administered medication on the doping control form. Therefore the FISA Doping Hearing Panel decides to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension.